Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
复制标题
DOI:
10.1186/s13024-021-00486-9
复制
发表时间:
2021-09-09
影响因子:
15.1
通讯作者:
Borchelt DR
中科院分区:
文献类型:
--
作者:
Lloyd GM;Dhillon JS;Gorion KM;Riffe C;Fromholt SE;Xia Y;Giasson BI;Borchelt DR
The misfolding of host-encoded proteins into pathological prion conformations is a defining characteristic of many neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and Lewy body dementia. A current area of intense study is the way in which the pathological deposition of these proteins might influence each other, as various combinations of co-pathology between prion-capable proteins are associated with exacerbation of disease. A spectrum of pathological, genetic and biochemical evidence provides credence to the notion that amyloid β (Aβ) accumulation can induce and promote α-synuclein pathology, driving neurodegeneration. To assess the interplay between α-synuclein and Aβ on protein aggregation kinetics, we crossed mice expressing human α-synuclein (M20) with APPswe/PS1dE9 transgenic mice (L85) to generate M20/L85 mice. We then injected α-synuclein preformed fibrils (PFFs) unilaterally into the hippocampus of 6-month-old mice, harvesting 2 or 4 months later. Immunohistochemical analysis of M20/L85 mice revealed that pre-existing Aβ plaques exacerbate the spread and deposition of induced α-synuclein pathology. This process was associated with increased neuroinflammation. Unexpectedly, the injection of α-synuclein PFFs in L85 mice enhanced the deposition of Aβ; whereas the level of Aβ deposition in M20/L85 bigenic mice, injected with α-synuclein PFFs, did not differ from that of mice injected with PBS. These studies reveal novel and unexpected interplays between α-synuclein pathology, Aβ and neuroinflammation in mice that recapitulate the pathology of Alzheimer’s disease and Lewy body dementia. The online version contains supplementary material available at 10.1186/s13024-021-00486-9.
登录
查看更多内容
影响因子:
15.1
作者:
Chakrabarty P;Herring A;Ceballos-Diaz C;Das P;Golde TE
通讯作者:
Golde TE
DOI:
10.1186/alzrt274
发表时间:
2014
期刊:
Alzheimer's research & therapy
影响因子:
--
作者:
Donaghy PC;McKeith IG
通讯作者:
McKeith IG
DOI:
10.1016/s1050-3862(96)00167-2
发表时间:
1996-12-01
期刊:
GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING
影响因子:
--
作者:
Borchelt, DR;Davis, J;Price, DL
通讯作者:
Price, DL
影响因子:
--
作者:
Carmona, Susana;Hardy, John;Guerreiro, Rita
通讯作者:
Guerreiro, Rita
影响因子:
4.8
作者:
Emmer, Kristel L.;Waxman, Elisa A.;Giasson, Benoit I.
通讯作者:
Giasson, Benoit I.